We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
-4.64%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$11.8B
AUM Growth
+$1.34B
Cap. Flow
+$2.18B
Cap. Flow %
18.39%
Top 10 Hldgs %
3.51%
Holding
4,052
New
613
Increased
1,643
Reduced
1,246
Closed
518

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$34.6M
2
WDAY icon
Workday
WDAY
+$33.5M
3
FRC
First Republic Bank
FRC
+$31.8M
4
ZTS icon
Zoetis
ZTS
+$31.3M
5
SYF icon
Synchrony
SYF
+$31M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$35.7M
2
HON icon
Honeywell
HON
+$31.7M
3
IP icon
International Paper
IP
+$30.5M
4
ADM icon
Archer Daniels Midland
ADM
+$23.8M
5
EMR icon
Emerson Electric
EMR
+$22.5M

Sector Composition

Rank Sector Weight
1 Technology 18.12%
2 Financials 17.75%
3 Healthcare 12.17%
4 Consumer Discretionary 11.8%
5 Industrials 11.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BFAC.WS
3301
DELISTED
Battery Future Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
BFAC.WS
$75K ﹤0.01%
+278,976
New +$85.4K
MFGP
3302
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
$75K ﹤0.01%
+14,169
New +$78.1K
DSP icon
3303
Viant Technology
DSP
$282M
$74K ﹤0.01%
+11,292
New +$86.1K
REFI
3304
Chicago Atlantic Real Estate Finance
REFI
$260M
$74K ﹤0.01%
4,200
+1,085
+35% +$20.1K
OMGA
3305
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$74K ﹤0.01%
11,847
+11,766
+14,526% +$120K
OHAAW
3306
DELISTED
OPY Acquisition Corp. I Warrant
OHAAW
$74K ﹤0.01%
+183,768
New +$82.7K
AMRN
3307
Amarin Corp
AMRN
$298M
$73K ﹤0.01%
1,107
-5,468
-83% -$361K
MSI icon
3308
Motorola Solutions
MSI
$76.5B
$73K ﹤0.01%
300
-18,154
-98% -$4.22M
VATE icon
3309
INNOVATE Corp
VATE
$97.3M
$73K ﹤0.01%
+1,989
New +$73.8K
MNTN.WS
3310
DELISTED
Everest Consolidator Acquisition Corporation Warrants, each whole warrant exercisable for one share of Class A Common Stock, at an exercise price of $11.50
MNTN.WS
$73K ﹤0.01%
+364,364
New +$115K
SCOR icon
3311
Comscore
SCOR
$106M
$72K ﹤0.01%
1,245
+578
+87% +$33.1K
QIWI
3312
DELISTED
QIWI PLC
QIWI
$72K ﹤0.01%
15,909
-1,485
-9% -$11K
ETNB
3313
DELISTED
89bio
ETNB
$71K ﹤0.01%
+18,932
New +$122K
PRPL icon
3314
Purple Innovation
PRPL
$39.6M
$71K ﹤0.01%
+483
New +$95.1K
SLQT icon
3315
SelectQuote
SLQT
$123M
$71K ﹤0.01%
25,454
+16,766
+193% +$80.8K
REGN icon
3316
Regeneron Pharmaceuticals
REGN
$83.2B
$70K ﹤0.01%
100
-9,188
-99% -$5.81M
DCH
3317
Dauch Corp
DCH
$1.58B
$69K ﹤0.01%
8,920
-183,900
-95% -$1.57M
CYH icon
3318
Community Health Systems
CYH
$415M
$69K ﹤0.01%
5,795
-283,138
-98% -$3.44M
HR icon
3319
Healthcare Realty
HR
$6.73B
$69K ﹤0.01%
2,206
-130,260
-98% -$4.1M
LX
3320
LexinFintech Holdings
LX
$242M
$69K ﹤0.01%
26,490
-15,716
-37% -$52K
RIOT icon
3321
Riot Platforms
RIOT
$7.34B
$69K ﹤0.01%
3,282
-6,905
-68% -$125K
VINC
3322
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$69K ﹤0.01%
863
+651
+307% +$80.4K
ADALW
3323
DELISTED
Anthemis Digital Acquisitions I Corp Warrant
ADALW
$68K ﹤0.01%
+261,414
New +$105K
SMED
3324
DELISTED
Sharps Compliance Corp
SMED
$68K ﹤0.01%
+11,481
New +$72.1K
AMRX icon
3325
Amneal Pharmaceuticals
AMRX
$5.71B
$66K ﹤0.01%
15,830
-37,171
-70% -$165K
131 132
133
134 135

Similar funds

GIM
Glenmede Investment Management Philadelphia, Pennsylvania $20.7B AUM
ECM
Eisler Capital Management London, United Kingdom $22.6B AUM 9.36% 1-Year Est. Return
JFL
Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
WIM
Waverton Investment Management London, United Kingdom $7.77B AUM 25.07% 1-Year Est. Return
AIM
AXA Investment Managers Puteaux, France $37.1B AUM
SIG
Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return

Cubist Systematic Strategies's Q1 2022 Portfolio in Review

As of Q1 2022, Cubist Systematic Strategies held 4,052 positions worth $11.8B, up 13% from $10.5B the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.

Cubist Systematic Strategies deployed $2.18B of net new capital in Q1 2022, opening 613 new positions and adding to 1,643 existing holdings. Its largest new stake was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Medtronic, an estimated $35.7M trimmed.

  • Cubist Systematic Strategies's largest Q1 2022 buy was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.
  • Cubist Systematic Strategies added most to Abbott in Q1 2022, an estimated $34.6M increase.
  • Cubist Systematic Strategies's biggest Q1 2022 reduction was Medtronic, cutting an estimated $35.7M.
  • Cubist Systematic Strategies fully exited Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant in Q1 2022, selling an estimated $20.6M.
  • Cubist Systematic Strategies's ten largest holdings make up 3.5% of its $11.8B portfolio in Q1 2022.
  • Cubist Systematic Strategies opened 613 new positions and closed 518 in Q1 2022.
  • Cubist Systematic Strategies's portfolio value rose 13% quarter-over-quarter to $11.8B.

Based on Cubist Systematic Strategies's 13F filing for Q1 2022, filed 16 May 2022.